Chimerism in peripheral blood of sensitized patients waiting for renal transplantation: Clinical implications

Transplantation

Volumn 69, Issue 4, 2000, Pages 538-544

  Sivasai, Krovvidi S R ^a   Jendrisak, Martin ^a,b   Duffy, Brian F ^a   Phelan, Donna ^a   Ravenscraft, Mark ^a,b   Howard, Todd ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Johns Mercy Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN;

ANTIBODY TITER; ARTICLE; BLOOD; BLOOD ANALYSIS; BLOOD GROUP TYPING; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIZATION;

EID: 0034052562     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200002270-00013     Document Type: Article

References (44)

1. Starzl T, Trucco M, Zeevi A, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340: 876.
2. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272.
3. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microchimerism and allograft survival. Immunol Today 1996; 17: 577.
4. Flye MW, Burton K, Mohanakumar T, et al. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995; 60: 1395.
5. Ricordi C, Karatzas T, Nery J, et al. High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing. Transplantation 1997; 63: 7.
6. Adams PT, Davenport RD, Reardon DA, Roth MS. Detection of circulating donor white blood cells in patients receiving multiple transfusions. Blood 1992; 80: 551.
7. Fontes P, Rao AS, Demetris AJ, et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 1994; 344: 151.
8. Schlitt HJ, Hundrieser J, Ringe B, Pichlmayr R. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med 1994; 330: 646.
9. Molleston JP, Alevy YG, SivaSai KSR, Mohanakumar T, Howard TK. Evidence that pediatric liver transplant recipients may undergo late rejection episodes in spite of donor-specific microchimerism. Transplantation 1996; 61: 656.
10. SivaSai KSR, Alevy Y, Duffy B, et al. Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism. Transplantation 1997; 64: 427.
11. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria M. Male fetal progenitor cells persist in maternal blood for as long as 27 years pospartum. Proc Natl Acad Sci USA 1996; 93: 705.
12. Bonney EA, Matzinger P. The maternal immune system's interaction with circulating fetal cells. J Immunol 1997; 158: 40.
13. Liou JD, Hsieh TT, Pai CC. Presence of cells of fetal origin in maternal circulation of pregnant women. Ann NY Acad Sci 1994; 731: 237.
14. Bianchi DW, Shuber AP, DeMaria MA, Fougner AC, Klinger KW. Fetal cells in maternal blood: determination of purity and yield by quantitative polymerase chain reaction. Am J Obstet Gynecol 1994; 171: 922.
15. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998; 338: 1186.
16. Opelz G. Kidney transplantation in sensitized patients. Transplant Proc 1987; 19: 3737.
17. Alarif L, Rodriguez R, Light JA. Influence of pre-transplant antibody on early allograft rejection. Transplant Proc 1987; 19: 771.
18. Braun WE. Laboratory and clinical management of the highly sensitized organ transplant recipient. Human Immunol 1989; 26: 245.
19. Bouma GJ, van Caubergh P, van Bree S, et al. Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation. Transplantation 1996; 62: 672.
20. Stastny P. Tissue typing antisera from immunication by pregnancy. Tissue Antigens 1972; 2: 123.
21. Salvatierra Jr O, Iwaki Y, Vincenti F, et al. Update of the University of California at San Francisco experience with donor-specific blood transfusions. Transplant Proc 1982; 14: 363.
22. Scornik JC, Salomon DR, Lim PB, Howard RJ, Pfaff WW. Posttransplant antidonor antibodies and graft rejection. Transplantation 1989; 47: 287.
23. Scornik JC, Brunson ME, Howard RJ, Pfaff WW. Alloimmunization, memory, and the interpretation of crossmatch results for renal transplantation. Transplantation 1992; 54: 389.
24. Dzik WH. Mononuclear cell microchimerism and the immunomodulatory effect of transfusion. Transfusion 1994; 34: 1007.
25. Gurland HJ, Blumenstein M, Lysaght MJ, Samtleben W, Stoffner D. Plasmapheresis in renal transplantation. Kidney Int 1983; 23: S82.
26. Hillebrand G, Castro LA, Samtleben W, et al. Removal of preformed cytotoxic antibodies in highly sensitized patients using plasma exchange and immunosuppressive therapy, azathioprine, or cyclosporine prior to renal transplantation. Transplant Proc 1985; 17: 2501.
27. Kuruvila KC, Raman G, Shah BG, Krishnaswamy PR. Pretransplant plasmapheresis in the prevention of acute renal graft rejection. J Assoc Physicians India 1982; 30: 127.
28. Kupin WL, Venkat KK, Hayashi H, Mozes MF, Oh HK, Watt R. Removal of lymphocytotoxicity antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients. Transplantation 1991; 51(2): 324.
29. Palmer A, Taube D, Welsh K, Bewick M, Gjorstrup P, Thick M. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable transplantation. Lancet 1989; 1: 10.
30. Branda RF, Klausner JS, Miller WJ, Soltis RD. Specific removal of antibodies with an immunoadsorption system. Transfusion 1984; 24: 157.
31. Yadin O, Sekiya NM, Ettenger RB. Intravenous immunoglobulin (IVIg) reduces antibody responses in highly sensitized dialysis patients. J Am Soc Nephrol 1992; 3: 887.
32. Tyan D, Li V, Czer L, Trento A, Jordan SC. Intravenous immunoglobulin suppression of HLA alloantibody in highly-sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994; 57: 553.
33. Glotz D, Haymann J, Naiudet P, Lang P, Druet P, Bairety J. Successful kidney transplantation of immunized patients after desensitization with normal human polyclonal immunoglobulins. Transplant Proc 1995; 27: 1038.
34. Kawasaki ES. Sample preparation from blood, cells and other fluids. In: Innis MA, Gelfand FH, Sninsky JJ, White TJ, eds. PCR protocols: a guide to methods and applications. San Diego, CA, Academic Press, 1990; 146.
35. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503.
36. Hongyo T, Buzard GS, Calvert RJ, Weghorst CM. 'Cold SSCF': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucl Acid Res 1993; 21: 3637.
37. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1153.
38. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995; 13: 622.
39. Bainbridge DR. Elimination of allogeneic lymphocytes by mice. Immunol Rev 1983; 73: 5.
40. Rolstad B, Wonigeit K, Vaage JT. Alloreactive rat natural killer (NK) cells in vivo and in vitro: the role of the major histocompatibility complex (MHC). In: Rolstad B, ed. Natural immunity to normal hemapoietic cells. New York, CRC Press, 1994; 99.
41. Heslop BF, McNeilage LJ. Natural cytotoxicity: early killing of allogeneic lymphocytes in rats. Immunol Rev 1983; 73: 35.
42. + cells are responsible for the rapid elimination of allogeneic donor lymphoid cells. J Immunol 1996; 157: 4805.
43. Restifo NP, Esquivel F, Asher AL, et al. Defective presentation of endogenous antigens by a murine sarcoma: implications for the failure of an anti-tumor immune response. J Immunol 1991; 147: 1453.
44. Chauhan B, Phelan DL, Marsh JW, Mohanakumar T. Characterization of antiidiotypic antibodies to donor HLA developed following liver transplantation. Transplantation 1993; 56: 443.